Collins Cynthia
Insider CIK 1405692 · CDXS Director · MXCT Director · EDIT Interim CEO, Director · DMTK Director · PSTX Director · CERT Director · GNVC President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDXS CODEXIS, INC. | A Award deriv | 2026-06-17 | 2026-06-18 | 66,350 | — | $0 | 66,350 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2026-06-17 | 2026-06-22 | 49,579 | — | $0 | 49,579 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2026-06-17 | 2026-06-22 | 30,421 | — | $0 | 111,310 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 51,846 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 50,790 | — | $0 | 50,790 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2025-06-18 | 2025-06-23 | 29,210 | — | $0 | 80,889 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2025-06-10 | 2025-06-12 | 40,983 | — | $0 | 112,157 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 36,089 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2025-03-28 | 2025-04-01 | 71,174 | — | $0 | 71,174 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 27,350 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 87,440 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 28,500 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 27,350 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 58,950 | — | $0 | 0 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2024-10-14 | 2024-10-16 | 97,698 | — | $0 | 97,698 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2024-10-14 | 2024-10-16 | 51,679 | — | $0 | 51,679 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-06-17 | 2024-06-18 | 27,350 | — | $0 | 27,350 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-06-17 | 2024-06-18 | 19,650 | — | $0 | 58,950 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 24,161 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 27,350 | — | $0 | 27,350 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-06-15 | 2023-06-16 | 19,650 | — | $0 | 39,300 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2023-06-01 | 2023-06-05 | 35,714 | — | $0 | 104,835 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2023-05-23 | 2023-05-25 | 8,663 | — | $0 | 8,663 | SEC↗ |
| CERT Certara, Inc. | M Exercise deriv | 2023-05-17 | 2023-05-19 | 9,067 | — | $0 | 0 | SEC↗ |
| CERT Certara, Inc. | M Exercise | 2023-05-17 | 2023-05-19 | 9,067 | — | $0 | 15,498 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 28,500 | — | $0 | 28,500 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-06-16 | 2022-06-17 | 19,650 | — | $0 | 19,650 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2022-05-26 | 2022-05-31 | 26,480 | — | $0 | 69,121 | SEC↗ |
| CERT Certara, Inc. | A Award deriv | 2022-05-17 | 2022-05-18 | 9,067 | — | $0 | 9,067 | SEC↗ |
| CERT Certara, Inc. | A Award | 2021-08-01 | 2021-08-03 | 6,431 | — | $0 | 6,431 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-07-23 | 2021-07-26 | 87,440 | — | $0 | 87,440 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2021-05-26 | 2021-05-28 | 4,497 | — | $0 | 37,980 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2021-05-26 | 2021-05-28 | 4,661 | — | $0 | 42,641 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2021-02-09 | 2021-02-10 | 1,262 | $66.65 | $84.1K | 43,760 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2020-08-20 | 2020-08-21 | 1,976 | $36.66 | $72.4K | 45,022 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2020-06-17 | 2020-06-19 | 8,000 | — | $0 | 33,483 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2020-02-06 | 2020-02-10 | 93,750 | — | $0 | 93,750 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2020-02-06 | 2020-02-10 | 15,625 | — | $0 | 46,998 | SEC↗ |
| DMTK DermTech, Inc. | A Award | 2020-01-30 | 2020-02-03 | 6,000 | — | $0 | 25,483 | SEC↗ |
| DMTK DermTech, Inc. | M Exercise deriv | 2019-12-31 | 2020-01-03 | 8,755 | — | $0 | 0 | SEC↗ |
| DMTK DermTech, Inc. | M Exercise | 2019-12-31 | 2020-01-03 | 8,755 | — | $0 | 19,483 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2019-09-11 | 2019-09-13 | 500,000 | — | $0 | 500,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2019-09-11 | 2019-09-13 | 250,000 | — | $0 | 250,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2019-09-11 | 2019-09-13 | 20,000 | — | $0 | 31,373 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2019-08-19 | 2019-08-21 | 5,193 | $25.83 | $134.1K | 11,373 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2019-08-19 | 2019-08-21 | 8,283 | — | $0 | 16,566 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2019-08-06 | 2019-08-07 | 8,283 | — | $0 | 16,566 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 11,538 | — | $0 | 11,538 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2019-01-31 | 2019-02-04 | 8,283 | — | $0 | 8,283 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2018-12-06 | 2018-12-10 | 23,076 | — | $0 | 23,076 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2013-01-23 | 2013-01-24 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2012-05-23 | 2012-05-25 | 250,000 | — | $0 | 250,000 | SEC↗ |